Merck Manual

Please confirm that you are a health care professional

honeypot link
Professional Version

Cystine-Binding Agents Used to Treat Urinary Disease in Animals

By

Patricia M. Dowling

, DVM, MSc, DACVIM, DACVCP, Department of Veterinary Biomedical Sciences, Western College of Veterinary Medicine, University of Saskatchewan

Reviewed/Revised Nov 2023

Cystinuria, with subsequent cystine urolith formation, results from a breed-related inherited disorder of renal tubular transport in dogs. Cystine stones are dissolved by means of dietary modification, administration of cystine-binding agents, or urinary alkalinization or neutralization (see Controlling Urine pH Controlling Urine pH in Animals The ideal urine pH is 7.0–7.5 in dogs and 6.3–6.6 in cats. If the urine pH remains low after diet modification, potassium citrate can be administered in food to increase the pH. Because it complexes... read more ).

Tiopronin and d-penicillamine are cystine-binding agents. Tiopronin has fewer adverse effects and is the recommended choice.

After cystine stones have been dissolved, a prevention protocol can be instituted. Dietary modification with or without urinary alkalinization may be enough to prevent stone formation; if uroliths recur, however, tiopronin may also be required.

The Cystine-Binding Agent Allopurinol for Treatment of Urinary Disease in Animals

Allopurinol is a synthetic isomer of hypoxanthine that binds to and inhibits the action of xanthine oxidase. It decreases the production of uric acid by inhibiting the conversion of hypoxanthine to xanthine and of xanthine to uric acid. The result is a decrease in serum and urine uric acid concentrations.

In combination with a low-purine diet, allopurinol is used to dissolve ammonium urate uroliths in affected Dalmatian dogs. Dosage should be decreased in dogs with renal insufficiency.

quiz link

Test your knowledge

Take a Quiz!
iOS ANDROID
iOS ANDROID
iOS ANDROID
TOP